Cardinal Health (CAH) Competitors $160.48 -0.64 (-0.39%) As of 01:21 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CAH vs. DXCM, HOLX, MMSI, AMN, COR, ELV, HAE, ITGR, MCK, and HSICShould you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include DexCom (DXCM), Hologic (HOLX), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Cencora (COR), Elevance Health (ELV), Haemonetics (HAE), Integer (ITGR), McKesson (MCK), and Henry Schein (HSIC). These companies are all part of the "medical" sector. Cardinal Health vs. Its Competitors DexCom Hologic Merit Medical Systems AMN Healthcare Services Cencora Elevance Health Haemonetics Integer McKesson Henry Schein Cardinal Health (NYSE:CAH) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Do insiders and institutionals have more ownership in CAH or DXCM? 87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.1% of Cardinal Health shares are owned by company insiders. Comparatively, 0.3% of DexCom shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media prefer CAH or DXCM? In the previous week, Cardinal Health had 10 more articles in the media than DexCom. MarketBeat recorded 28 mentions for Cardinal Health and 18 mentions for DexCom. DexCom's average media sentiment score of 1.38 beat Cardinal Health's score of 1.20 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardinal Health 21 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 12 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer CAH or DXCM? Cardinal Health presently has a consensus target price of $158.07, indicating a potential downside of 1.50%. DexCom has a consensus target price of $99.60, indicating a potential upside of 16.88%. Given DexCom's stronger consensus rating and higher probable upside, analysts clearly believe DexCom is more favorable than Cardinal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardinal Health 0 Sell rating(s) 3 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.79DexCom 0 Sell rating(s) 4 Hold rating(s) 16 Buy rating(s) 2 Strong Buy rating(s) 2.91 Is CAH or DXCM more profitable? DexCom has a net margin of 12.90% compared to Cardinal Health's net margin of 0.70%. DexCom's return on equity of 30.05% beat Cardinal Health's return on equity.Company Net Margins Return on Equity Return on Assets Cardinal Health0.70% -68.84% 4.21% DexCom 12.90%30.05%10.00% Which has more volatility and risk, CAH or DXCM? Cardinal Health has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500. Which has better valuation & earnings, CAH or DXCM? Cardinal Health has higher revenue and earnings than DexCom. Cardinal Health is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardinal Health$226.83B0.17$852M$6.4125.04DexCom$4.15B8.06$576.20M$1.3463.59 SummaryDexCom beats Cardinal Health on 13 of the 17 factors compared between the two stocks. Get Cardinal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CAH vs. The Competition Export to ExcelMetricCardinal HealthMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$38.30B$15.47B$5.51B$20.71BDividend Yield1.27%1.46%4.25%3.68%P/E Ratio25.0318.3228.2727.42Price / Sales0.172.28424.8970.78Price / Cash15.2816.8035.5321.88Price / Book-12.173.768.214.64Net Income$852M$430.42M$3.24B$994.58M7 Day Performance-0.91%-1.87%0.43%-0.94%1 Month Performance-2.68%4.12%7.84%5.16%1 Year Performance67.14%14.87%28.19%8.80% Cardinal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CAHCardinal Health4.8698 of 5 stars$160.48-0.4%$158.07-1.5%+68.8%$38.30B$226.83B25.0348,900Positive NewsAnalyst ForecastDXCMDexCom4.7837 of 5 stars$85.33+2.4%$98.50+15.4%-27.5%$33.46B$4.15B63.6810,300Positive NewsAnalyst ForecastHOLXHologic4.7124 of 5 stars$64.65-1.6%$78.75+21.8%-18.6%$14.41B$4.03B27.287,063Positive NewsAnalyst ForecastMMSIMerit Medical Systems4.6519 of 5 stars$93.60+0.1%$109.11+16.6%-3.6%$5.53B$1.36B45.887,400Positive NewsAnalyst ForecastAMNAMN Healthcare Services4.2444 of 5 stars$20.72-2.1%$32.08+54.8%-65.0%$793.27M$2.85B-4.792,968Analyst RevisionCORCencora4.4799 of 5 stars$297.00+0.6%$306.33+3.1%+32.1%$57.57B$638.56M34.4546,000Positive NewsAnalyst ForecastELVElevance Health4.9476 of 5 stars$339.77-0.3%$491.07+44.5%-37.7%$76.77B$177.01B13.26104,200Trending NewsEarnings ReportAnalyst ForecastGap DownHAEHaemonetics4.887 of 5 stars$76.59+1.4%$97.30+27.0%-18.7%$3.68B$1.36B23.143,023Analyst RevisionITGRInteger3.8752 of 5 stars$119.61-0.3%$145.00+21.2%-6.0%$4.17B$1.72B56.6911,000News CoveragePositive NewsUpcoming EarningsMCKMcKesson4.5876 of 5 stars$716.46+1.0%$706.83-1.3%+22.5%$89.64B$359.05B27.7445,000Positive NewsAnalyst ForecastInsider TradeHSICHenry Schein4.2756 of 5 stars$70.68-3.7%$78.36+10.9%+2.6%$8.60B$12.67B22.0925,000News CoverageAnalyst DowngradeAnalyst Revision Related Companies and Tools Related Companies DexCom Competitors Hologic Competitors Merit Medical Systems Competitors AMN Healthcare Services Competitors Cencora Competitors Elevance Health Competitors Haemonetics Competitors Integer Competitors McKesson Competitors Henry Schein Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CAH) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardinal Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardinal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
